{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,17]],"date-time":"2026-09-17T03:07:41Z","timestamp":1789614461407,"version":"build-2803163510"},"reference-count":100,"publisher":"Springer Science and Business Media LLC","issue":"5","license":[{"start":{"date-parts":[[2012,8,21]],"date-time":"2012-08-21T00:00:00Z","timestamp":1345507200000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Curr Treat Options Cardio Med"],"published-print":{"date-parts":[[2012,10]]},"DOI":"10.1007\/s11936-012-0194-5","type":"journal-article","created":{"date-parts":[[2012,8,20]],"date-time":"2012-08-20T06:55:37Z","timestamp":1345445737000},"page":"455-472","source":"Crossref","is-referenced-by-count":8,"title":["The Medical Management of Pediatric Arrhythmias"],"prefix":"10.1007","volume":"14","author":[{"given":"Carolina","family":"Escudero","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Roxane","family":"Carr","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shubhayan","family":"Sanatani","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2012,8,21]]},"reference":[{"key":"194_CR1","doi-asserted-by":"crossref","first-page":"1717","DOI":"10.1253\/circj.CJ-09-0123","volume":"73","author":"SN Chiu","year":"2009","unstructured":"Chiu SN, Lu CW, Chang CW, et al. Radiofrequency catheter ablation of supraventricular tachycardia in infants and toddlers. Circ J. 2009;73:1717\u201321.","journal-title":"Circ J"},{"key":"194_CR2","doi-asserted-by":"crossref","first-page":"304","DOI":"10.1111\/j.1540-8159.2010.02953.x","volume":"34","author":"KK Collins","year":"2011","unstructured":"Collins KK, Schaffer MS. Use of cryoablation for treatment of tachyarrhythmias in 2010: survey of current practices of pediatric electrophysiologists. Pacing Clin Electrophysiol. 2011;34:304\u20138.","journal-title":"Pacing Clin Electrophysiol"},{"key":"194_CR3","doi-asserted-by":"crossref","first-page":"950","DOI":"10.1046\/j.1460-9592.2001.00950.x","volume":"24","author":"CC Chiu","year":"2001","unstructured":"Chiu CC, McCrindle BW, Hamilton RM, et al. Clinical use of permanent pacemaker for conversion of intraatrial reentry tachycardia in children. Pacing Clin Electrophysiol. 2001;24:950\u20136.","journal-title":"Pacing Clin Electrophysiol"},{"key":"194_CR4","doi-asserted-by":"crossref","first-page":"200","DOI":"10.1111\/j.1747-0803.2008.00192.x","volume":"3","author":"CS Snyder","year":"2008","unstructured":"Snyder CS, Dobson G, Rollinson N, Graumann R. Suppression of intra-atrial reentrant tachycardia in patients with atrial overdrive pacing. Congenital Heart Dis. 2008;3:200\u20134.","journal-title":"Congenital Heart Dis"},{"issue":"Suppl","key":"194_CR5","doi-asserted-by":"crossref","first-page":"191","DOI":"10.1016\/S0022-0736(95)80055-7","volume":"28","author":"TR Chay","year":"1995","unstructured":"Chay TR. Why are some antiarrhythmic drugs proarrhythmic? Cardiac arrhythmia study by bifurcation analysis. J Electrocardiol. 1995;28(Suppl):191\u20137.","journal-title":"J Electrocardiol"},{"issue":"Suppl 6","key":"194_CR6","first-page":"S65","volume":"17","author":"PJ Podrid","year":"1991","unstructured":"Podrid PJ. Safety and toxicity of antiarrhythmic drug therapy: benefit versus risk. J Cardiovasc Pharmacol. 1991;17 Suppl 6:S65\u201373.","journal-title":"J Cardiovasc Pharmacol"},{"key":"194_CR7","doi-asserted-by":"crossref","first-page":"1364","DOI":"10.1161\/01.CIR.84.3.1364","volume":"84","author":"CF Starmer","year":"1991","unstructured":"Starmer CF, Lastra AA, Nesterenko VV, Grant AO. Proarrhythmic response to sodium channel blockade. Theoretical model and numerical experiments. Circulation. 1991;84:1364\u201377.","journal-title":"Circulation"},{"key":"194_CR8","doi-asserted-by":"crossref","first-page":"123","DOI":"10.1002\/j.1552-4604.1991.tb03695.x","volume":"31","author":"WEM Vaughan","year":"1991","unstructured":"Vaughan WEM. Significance of classifying antiarrhythmic actions since the cardiac arrhythmia suppression trial. J Clin Pharmacol. 1991;31:123\u201335.","journal-title":"J Clin Pharmacol"},{"key":"194_CR9","doi-asserted-by":"crossref","first-page":"2112","DOI":"10.1016\/j.clinthera.2008.11.020","volume":"30","author":"MC Nahata","year":"2008","unstructured":"Nahata MC, Allen Jr LV. Extemporaneous drug formulations. Clin Ther. 2008;30:2112\u20139.","journal-title":"Clin Ther"},{"key":"194_CR10","doi-asserted-by":"crossref","first-page":"506","DOI":"10.1345\/aph.1C333","volume":"37","author":"MC Nahata","year":"2003","unstructured":"Nahata MC, Morosco RS. Stability of sotalol in two liquid formulations at two temperatures. Ann Pharmacother. 2003;37:506\u20139.","journal-title":"Ann Pharmacother"},{"key":"194_CR11","doi-asserted-by":"crossref","first-page":"257","DOI":"10.1016\/S1086-5802(16)31067-1","volume":"40","author":"MC Nahata","year":"2000","unstructured":"Nahata MC, Morosco RS, Hipple TF. Stability of mexiletine in two extemporaneous liquid formulations stored under refrigeration and at room temperature. J Am Pharm Assoc (Wash). 2000;40:257\u20139.","journal-title":"J Am Pharm Assoc (Wash)"},{"key":"194_CR12","doi-asserted-by":"crossref","first-page":"241","DOI":"10.1002\/bdd.505","volume":"27","author":"HJ Olguin","year":"2006","unstructured":"Olguin HJ, Perez CF, Perez JF, et al. Bioavailability of an extemporaneous suspension of propafenone made from tablets. Biopharm Drug Dispos. 2006;27:241\u20135.","journal-title":"Biopharm Drug Dispos"},{"key":"194_CR13","first-page":"1467","volume":"49","author":"DB Wiest","year":"1992","unstructured":"Wiest DB, Garner SS, Pagacz LR, Zeigler V. Stability of flecainide acetate in an extemporaneously compounded oral suspension. Am J Hosp Pharm. 1992;49:1467\u201370.","journal-title":"Am J Hosp Pharm"},{"key":"194_CR14","doi-asserted-by":"crossref","first-page":"1112","DOI":"10.1093\/oxfordjournals.eurheartj.a059846","volume":"12","author":"The 'Sicilian Gambit'","year":"1991","unstructured":"The 'Sicilian Gambit'. A new approach to the classification of antiarrhythmic drugs based on their actions on arrhythmogenic mechanisms. The Task Force of the Working Group on Arrhythmias of the European Society of Cardiology. Eur Heart J. 1991;12:1112\u201331.","journal-title":"Eur Heart J"},{"key":"194_CR15","doi-asserted-by":"crossref","first-page":"743","DOI":"10.2174\/138161208784007734","volume":"14","author":"PP Karpawich","year":"2008","unstructured":"Karpawich PP, Pettersen MD, Gupta P, Shah N. Infants and children with tachycardia: natural history and drug administration. Curr Pharm Des. 2008;14:743\u201352.","journal-title":"Curr Pharm Des"},{"key":"194_CR16","doi-asserted-by":"crossref","first-page":"268","DOI":"10.1001\/archpediatrics.2008.547","volume":"163","author":"JC Salerno","year":"2009","unstructured":"Salerno JC, Seslar SP. Supraventricular tachycardia. Arch Pediatr Adolesc Med. 2009;163:268\u201374.","journal-title":"Arch Pediatr Adolesc Med"},{"key":"194_CR17","doi-asserted-by":"crossref","unstructured":"Ceresnak SR, Tanel RE, Pass RH, et al. Clinical and electrophysiologic characteristics of antidromic tachycardia in children with Wolff\u2013Parkinson\u2013White Syndrome. Pacing Clin Electrophysiol 2012 (in press).","DOI":"10.1111\/j.1540-8159.2011.03317.x"},{"key":"194_CR18","doi-asserted-by":"crossref","first-page":"1190","DOI":"10.1136\/adc.2005.077636","volume":"90","author":"J Dixon","year":"2005","unstructured":"Dixon J, Foster K, Wyllie J, Wren C. Guidelines and adenosine dosing in supraventricular tachycardia. Arch Dis Child. 2005;90:1190\u20131.","journal-title":"Arch Dis Child"},{"key":"194_CR19","doi-asserted-by":"crossref","first-page":"911","DOI":"10.1136\/emj.2008.069252","volume":"26","author":"S Connor","year":"2009","unstructured":"Connor S. Treatment of supraventricular tachycardia with adenosine in children: size does matter. Emerg Med J. 2009;26:911\u20132.","journal-title":"Emerg Med J"},{"key":"194_CR20","doi-asserted-by":"crossref","first-page":"139","DOI":"10.1016\/S0022-3476(94)70270-5","volume":"124","author":"MA Ralston","year":"1994","unstructured":"Ralston MA, Knilans TK, Hannon DW, Daniels SR. Use of adenosine for diagnosis and treatment of tachyarrhythmias in pediatric patients. J Pediatr. 1994;124:139\u201343.","journal-title":"J Pediatr"},{"key":"194_CR21","doi-asserted-by":"crossref","first-page":"53","DOI":"10.1046\/j.1440-1754.1998.00153.x","volume":"34","author":"MC Sherwood","year":"1998","unstructured":"Sherwood MC, Lau KC, Sholler GF. Adenosine in the management of supraventricular tachycardia in children. J Paediatr Child Health. 1998;34:53\u20136.","journal-title":"J Paediatr Child Health"},{"key":"194_CR22","doi-asserted-by":"crossref","first-page":"204","DOI":"10.1136\/hrt.62.3.204","volume":"62","author":"J Till","year":"1989","unstructured":"Till J, Shinebourne EA, Rigby ML, et al. Efficacy and safety of adenosine in the treatment of supraventricular tachycardia in infants and children. Brit Heart J. 1989;62:204\u201311.","journal-title":"Brit Heart J"},{"key":"194_CR23","doi-asserted-by":"crossref","first-page":"386","DOI":"10.1111\/j.1542-474X.2008.00245.x","volume":"13","author":"C Ertan","year":"2008","unstructured":"Ertan C, Atar I, Gulmez O, et al. Adenosine-induced ventricular arrhythmias in patients with supraventricular tachycardias. Ann Noninvas Electro. 2008;13:386\u201390.","journal-title":"Ann Noninvas Electro"},{"key":"194_CR24","doi-asserted-by":"crossref","first-page":"433","DOI":"10.2217\/fca.10.66","volume":"6","author":"A El-Menyar","year":"2010","unstructured":"El-Menyar A, Gehani A. Adenosine-induced tachyarrhythmia and cardiac arrest. Future Cardiol. 2010;6:433\u20136.","journal-title":"Future Cardiol"},{"key":"194_CR25","doi-asserted-by":"crossref","first-page":"263","DOI":"10.1136\/hrt.69.3.263","volume":"69","author":"AC Rankin","year":"1993","unstructured":"Rankin AC, Rae AP, Houston A. Acceleration of ventricular response to atrial flutter after intravenous adenosine. Brit Heart J. 1993;69:263\u20135.","journal-title":"Brit Heart J"},{"key":"194_CR26","doi-asserted-by":"crossref","first-page":"134","DOI":"10.1161\/CIRCEP.109.901629","volume":"3","author":"PM Chang","year":"2010","unstructured":"Chang PM, Silka MJ, Moromisato DY, Bar-Cohen Y. Amiodarone versus procainamide for the acute treatment of recurrent supraventricular tachycardia in pediatric patients. Circ Arrhythm Electrophysiol. 2010;3:134\u201340.","journal-title":"Circ Arrhythm Electrophysiol"},{"key":"194_CR27","doi-asserted-by":"crossref","first-page":"82","DOI":"10.1097\/PEC.0b013e3181ce2f6a","volume":"26","author":"E Dilber","year":"2010","unstructured":"Dilber E, Mutlu M, Dilber B, et al. Intravenous amiodarone used alone or in combination with digoxin for life-threatening supraventricular tachyarrhythmia in neonates and small infants. Pediatr Emerg Care. 2010;26:82\u20134.","journal-title":"Pediatr Emerg Care"},{"key":"194_CR28","doi-asserted-by":"crossref","first-page":"629","DOI":"10.1093\/europace\/eun069","volume":"10","author":"F Drago","year":"2008","unstructured":"Drago F, Silvetti MS, De Santis A, et al. Paroxysmal reciprocating supraventricular tachycardia in infants: electrophysiologically guided medical treatment and long-term evolution of the re-entry circuit. Europace. 2008;10:629\u201335.","journal-title":"Europace"},{"key":"194_CR29","doi-asserted-by":"crossref","first-page":"753","DOI":"10.2174\/138161208784007644","volume":"14","author":"C Ratnasamy","year":"2008","unstructured":"Ratnasamy C, Rossique-Gonzalez M, Young ML. Pharmacological therapy in children with atrioventricular reentry: which drug? Curr Pharm Des. 2008;14:753\u201361.","journal-title":"Curr Pharm Des"},{"issue":"Suppl 3","key":"194_CR30","doi-asserted-by":"crossref","first-page":"30","DOI":"10.3109\/14767058.2010.517937","volume":"23","author":"MC Tavera","year":"2010","unstructured":"Tavera MC, Bassareo PP, Neroni P, et al. Supraventricular tachycardia in neonates: antiarrhythmic drug choice dilemma. J Matern-Fetal Neo Med. 2010;23 Suppl 3:30\u20133.","journal-title":"J Matern-Fetal Neo Med"},{"key":"194_CR31","doi-asserted-by":"crossref","first-page":"199","DOI":"10.1007\/s00246-005-1126-x","volume":"27","author":"KK Wong","year":"2006","unstructured":"Wong KK, Potts JE, Etheridge SP, Sanatani S. Medications used to manage supraventricular tachycardia in the infant a North American survey. Pediatr Cardiol. 2006;27:199\u2013203.","journal-title":"Pediatr Cardiol"},{"key":"194_CR32","doi-asserted-by":"crossref","first-page":"770","DOI":"10.2174\/138161208784007707","volume":"14","author":"G Fazio","year":"2008","unstructured":"Fazio G, Visconti C, D'Angelo L, et al. Pharmacological therapy in children with atrial fibrillation and atrial flutter. Curr Pharm Des. 2008;14:770\u20135.","journal-title":"Curr Pharm Des"},{"key":"194_CR33","doi-asserted-by":"crossref","first-page":"521","DOI":"10.1007\/s11936-000-0047-5","volume":"2","author":"S Balaji","year":"2000","unstructured":"Balaji S. Supraventricular tachycardia in children. Curr Treat Options Cardiovasc Med. 2000;2:521\u20138.","journal-title":"Curr Treat Options Cardiovasc Med"},{"key":"194_CR34","doi-asserted-by":"crossref","first-page":"523 e3","DOI":"10.1016\/j.cjca.2010.12.043","volume":"27","author":"MJ Kantoch","year":"2011","unstructured":"Kantoch MJ, Gulamhusein SS, Sanatani S. Short- and long-term outcomes in children undergoing radiofrequency catheter ablation before their second birthday. Can J Cardiol. 2011;27:523 e3\u20139.","journal-title":"Can J Cardiol"},{"key":"194_CR35","doi-asserted-by":"crossref","first-page":"766","DOI":"10.2174\/138161208784007716","volume":"14","author":"R Bouhouch","year":"2008","unstructured":"Bouhouch R, El Houari T, Fellat I, Arharbi M. Pharmacological therapy in children with nodal reentry tachycardia: when, how and how long to treat the affected patients. Curr Pharm Des. 2008;14:766\u20139.","journal-title":"Curr Pharm Des"},{"key":"194_CR36","doi-asserted-by":"crossref","first-page":"454","DOI":"10.1007\/s00246-006-1279-2","volume":"27","author":"F Drago","year":"2006","unstructured":"Drago F, Grutter G, Silvetti MS, et al. Atrioventricular nodal reentrant tachycardia in children. Pediatr Cardiol. 2006;27:454\u20139.","journal-title":"Pediatr Cardiol"},{"key":"194_CR37","doi-asserted-by":"crossref","first-page":"956","DOI":"10.1016\/S0002-9149(98)00512-8","volume":"82","author":"GJ Gross","year":"1998","unstructured":"Gross GJ, Epstein MR, Walsh EP, Saul JP. Characteristics, management, and midterm outcome in infants with atrioventricular nodal reentry tachycardia. Am J Cardiol. 1998;82:956\u201360.","journal-title":"Am J Cardiol"},{"key":"194_CR38","doi-asserted-by":"crossref","first-page":"1493","DOI":"10.1016\/j.jacc.2003.08.013","volume":"42","author":"C Blomstrom-Lundqvist","year":"2003","unstructured":"Blomstrom-Lundqvist C, Scheinman MM, Aliot EM, et al. ACC\/AHA\/ESC guidelines for the management of patients with supraventricular arrhythmias\u2014executive summary. a report of the American college of cardiology\/American heart association task force on practice guidelines and the European society of cardiology committee for practice guidelines (writing committee to develop guidelines for the management of patients with supraventricular arrhythmias) developed in collaboration with NASPE-Heart Rhythm Society. J Am Coll Cardiol. 2003;42:1493\u2013531.","journal-title":"J Am Coll Cardiol"},{"key":"194_CR39","doi-asserted-by":"crossref","first-page":"110","DOI":"10.1016\/0002-8703(92)90927-N","volume":"124","author":"B Musto","year":"1992","unstructured":"Musto B, Cavallaro C, Musto A, et al. Flecainide single oral dose for management of paroxysmal supraventricular tachycardia in children and young adults. Am Heart J. 1992;124:110\u20135.","journal-title":"Am Heart J"},{"key":"194_CR40","doi-asserted-by":"crossref","first-page":"101","DOI":"10.1136\/hrt.2004.054163","volume":"92","author":"G Vaksmann","year":"2006","unstructured":"Vaksmann G, D'Hoinne C, Lucet V, et al. Permanent junctional reciprocating tachycardia in children: a multicentre study on clinical profile and outcome. Heart. 2006;92:101\u20134.","journal-title":"Heart"},{"key":"194_CR41","first-page":"456","volume":"2","author":"F Drago","year":"2001","unstructured":"Drago F, Silvetti MS, Mazza A, et al. Permanent junctional reciprocating tachycardia in infants and children: effectiveness of medical and non-medical treatment. Ital heart J. 2001;2:456\u201361.","journal-title":"Ital heart J"},{"key":"194_CR42","doi-asserted-by":"crossref","first-page":"936","DOI":"10.1053\/euhj.1997.0860","volume":"19","author":"A Lindinger","year":"1998","unstructured":"Lindinger A, Heisel A, von Bernuth G, et al. Permanent junctional re-entry tachycardia. A multicentre long-term follow-up study in infants, children and young adults. Eur Heart J. 1998;19:936\u201342.","journal-title":"Eur Heart J"},{"key":"194_CR43","doi-asserted-by":"crossref","first-page":"508","DOI":"10.1007\/s00246-002-1514-4","volume":"23","author":"S Sanatani","year":"2002","unstructured":"Sanatani S, Hamilton RM, Gross GJ. Predictors of refractory tachycardia in infants with supraventricular tachycardia. Pediatr Cardiol. 2002;23:508\u201312.","journal-title":"Pediatr Cardiol"},{"key":"194_CR44","doi-asserted-by":"crossref","first-page":"1323","DOI":"10.1111\/j.1540-8159.1993.tb01719.x","volume":"16","author":"CL Case","year":"1993","unstructured":"Case CL, Gillette PC. Automatic atrial and junctional tachycardias in the pediatric patient: strategies for diagnosis and management. Pacing Clin Electrophysiol. 1993;16:1323\u201335.","journal-title":"Pacing Clin Electrophysiol"},{"key":"194_CR45","doi-asserted-by":"crossref","first-page":"1145","DOI":"10.1016\/0002-8703(95)90396-8","volume":"129","author":"U Bauersfeld","year":"1995","unstructured":"Bauersfeld U, Gow RM, Hamilton RM, Izukawa T. Treatment of atrial ectopic tachycardia in infants <6 months old. Am Heart J. 1995;129:1145\u20138.","journal-title":"Am Heart J"},{"key":"194_CR46","doi-asserted-by":"crossref","first-page":"283","DOI":"10.1016\/0002-9149(94)90376-X","volume":"74","author":"AA Dhala","year":"1994","unstructured":"Dhala AA, Case CL, Gillette PC. Evolving treatment strategies for managing atrial ectopic tachycardia in children. Am J Cardiol. 1994;74:283\u20136.","journal-title":"Am J Cardiol"},{"key":"194_CR47","doi-asserted-by":"crossref","first-page":"1410","DOI":"10.1093\/oxfordjournals.eurheartj.a060075","volume":"13","author":"G Bernuth von","year":"1992","unstructured":"von Bernuth G, Engelhardt W, Kramer HH, et al. Atrial automatic tachycardia in infancy and childhood. Eur Heart J. 1992;13:1410\u20135.","journal-title":"Eur Heart J"},{"key":"194_CR48","first-page":"402","volume":"137","author":"D Stambach","year":"2007","unstructured":"Stambach D, Bermet V, Bauersfeld U. Clinical recognition and treatment of atrial ectopic tachycardia in newborns. Swiss Med Wkly. 2007;137:402\u20136.","journal-title":"Swiss Med Wkly"},{"key":"194_CR49","doi-asserted-by":"crossref","first-page":"438","DOI":"10.1016\/j.jacc.2003.09.031","volume":"43","author":"JC Salerno","year":"2004","unstructured":"Salerno JC, Kertesz NJ, Friedman RA, Fenrich Jr AL. Clinical course of atrial ectopic tachycardia is age-dependent: results and treatment in children < 3 or > or =3 years of age. J Am Coll Cardiol. 2004;43:438\u201344.","journal-title":"J Am Coll Cardiol"},{"key":"194_CR50","doi-asserted-by":"crossref","first-page":"405","DOI":"10.1016\/S0002-9149(99)80567-0","volume":"75","author":"ZJ Naheed","year":"1995","unstructured":"Naheed ZJ, Strasburger JF, Benson Jr DW. Deal BJ: Natural history and management strategies of automatic atrial tachycardia in children. Am J Cardiol. 1995;75:405\u20137.","journal-title":"Am J Cardiol"},{"key":"194_CR51","doi-asserted-by":"crossref","first-page":"302","DOI":"10.1016\/S0002-8703(97)70224-2","volume":"133","author":"FA Casey","year":"1997","unstructured":"Casey FA, McCrindle BW, Hamilton RM, Gow RM. Neonatal atrial flutter: significant early morbidity and excellent long-term prognosis. Am Heart J. 1997;133:302\u20136.","journal-title":"Am Heart J"},{"issue":"Suppl A","key":"194_CR52","first-page":"45A","volume":"12","author":"RM Gow","year":"1996","unstructured":"Gow RM. Atrial fibrillation and flutter in children and in young adults with congenital heart disease. Can J Cardiol. 1996;12(Suppl A):45A\u20138A.","journal-title":"Can J Cardiol"},{"key":"194_CR53","doi-asserted-by":"crossref","first-page":"85","DOI":"10.1016\/j.pcl.2005.10.004","volume":"53","author":"SJ Doniger","year":"2006","unstructured":"Doniger SJ, Sharieff GQ. Pediatric dysrhythmias. Pediatr Clin North Am. 2006;53:85\u2013105. vi.","journal-title":"Pediatr Clin North Am"},{"key":"194_CR54","doi-asserted-by":"crossref","first-page":"113","DOI":"10.1097\/01.ANC.0000278209.11015.f7","volume":"7","author":"W Knirsch","year":"2007","unstructured":"Knirsch W, Kretschmar O, Vogel M, et al. Successful treatment of atrial flutter with amiodarone in a premature neonate. Case report and literature review. Adv Neonatal Care. 2007;7:113\u201321.","journal-title":"Adv Neonatal Care"},{"key":"194_CR55","doi-asserted-by":"crossref","first-page":"1003","DOI":"10.1111\/j.1540-8159.2007.00799.x","volume":"30","author":"AW Hoyer","year":"2007","unstructured":"Hoyer AW, Balaji S. The safety and efficacy of ibutilide in children and in patients with congenital heart disease. Pacing Clin Electrophysiol. 2007;30:1003\u20138.","journal-title":"Pacing Clin Electrophysiol"},{"key":"194_CR56","doi-asserted-by":"crossref","first-page":"422","DOI":"10.1023\/A:1021192526642","volume":"6","author":"EP Walsh","year":"2002","unstructured":"Walsh EP. Arrhythmias in patients with congenital heart disease. Card Electrophysiol Rev. 2002;6:422\u201330.","journal-title":"Card Electrophysiol Rev"},{"key":"194_CR57","doi-asserted-by":"crossref","first-page":"413","DOI":"10.1002\/clc.4960270711","volume":"27","author":"MS Horenstein","year":"2004","unstructured":"Horenstein MS, Karpawich PP, Epstein ML, Singh TP. Transthoracic echocardiography for precardioversion screening during atrial flutter\/fibrillation in young patients. Clin Cardiol. 2004;27:413\u20136.","journal-title":"Clin Cardiol"},{"key":"194_CR58","doi-asserted-by":"crossref","first-page":"211","DOI":"10.1007\/s12098-010-0276-x","volume":"78","author":"KR Jat","year":"2011","unstructured":"Jat KR, Lodha R, Kabra SK. Arrhythmias in children. Indian J Pediatr. 2011;78:211\u20138.","journal-title":"Indian J Pediatr"},{"key":"194_CR59","doi-asserted-by":"crossref","first-page":"e101","DOI":"10.1016\/j.jacc.2010.09.013","volume":"57","author":"V Fuster","year":"2011","unstructured":"Fuster V, Ryden LE, Cannom DS, et al. 2011 ACCF\/AHA\/HRS focused updates incorporated into the ACC\/AHA\/ESC 2006 Guidelines for the management of patients with atrial fibrillation: a report of the American College of Cardiology Foundation\/American Heart Association Task Force on Practice Guidelines developed in partnership with the European Society of Cardiology and in collaboration with the European Heart Rhythm Association and the Heart Rhythm Society. J Am Coll Cardiol. 2011;57:e101\u201398.","journal-title":"J Am Coll Cardiol"},{"key":"194_CR60","doi-asserted-by":"crossref","first-page":"1607","DOI":"10.1016\/S0003-4975(02)04014-6","volume":"74","author":"TM Hoffman","year":"2002","unstructured":"Hoffman TM, Bush DM, Wernovsky G, et al. Postoperative junctional ectopic tachycardia in children: incidence, risk factors, and treatment. Ann Thorac Surg. 2002;74:1607\u201311.","journal-title":"Ann Thorac Surg"},{"key":"194_CR61","doi-asserted-by":"crossref","first-page":"895","DOI":"10.1007\/s00134-007-0987-2","volume":"34","author":"JB Andreasen","year":"2008","unstructured":"Andreasen JB, Johnsen SP, Ravn HB. Junctional ectopic tachycardia after surgery for congenital heart disease in children. Intensive Care Med. 2008;34:895\u2013902.","journal-title":"Intensive Care Med"},{"key":"194_CR62","doi-asserted-by":"crossref","first-page":"335","DOI":"10.1016\/j.acvd.2008.10.016","volume":"102","author":"A Bouzas-Mosquera","year":"2009","unstructured":"Bouzas-Mosquera A, Rueda-Nunez F, Mosquera-Perez I. Postoperative junctional ectopic tachycardia. Arch Cardiovasc Dis. 2009;102:335\u20136.","journal-title":"Arch Cardiovasc Dis"},{"key":"194_CR63","doi-asserted-by":"crossref","first-page":"690","DOI":"10.1016\/j.jacc.2008.11.019","volume":"53","author":"KK Collins","year":"2009","unstructured":"Collins KK, Van Hare GF, Kertesz NJ, et al. Pediatric nonpost-operative junctional ectopic tachycardia medical management and interventional therapies. J Am Coll Cardiol. 2009;53:690\u20137.","journal-title":"J Am Coll Cardiol"},{"key":"194_CR64","doi-asserted-by":"crossref","first-page":"123","DOI":"10.1007\/s002469910018","volume":"21","author":"R Mandapati","year":"2000","unstructured":"Mandapati R, Byrum CJ, Kavey RE, et al. Procainamide for rate control of postsurgical junctional tachycardia. Pediatr Cardiol. 2000;21:123\u20138.","journal-title":"Pediatr Cardiol"},{"key":"194_CR65","doi-asserted-by":"crossref","first-page":"616","DOI":"10.1016\/j.athoracsur.2009.04.088","volume":"88","author":"L Kovacikova","year":"2009","unstructured":"Kovacikova L, Hakacova N, Dobos D, et al. Amiodarone as a first-line therapy for postoperative junctional ectopic tachycardia. Ann Thorac Surg. 2009;88:616\u201322.","journal-title":"Ann Thorac Surg"},{"key":"194_CR66","doi-asserted-by":"crossref","first-page":"133","DOI":"10.1007\/s00246-002-0276-3","volume":"24","author":"WP Laird","year":"2003","unstructured":"Laird WP, Snyder CS, Kertesz NJ, et al. Use of intravenous amiodarone for postoperative junctional ectopic tachycardia in children. Pediatr Cardiol. 2003;24:133\u20137.","journal-title":"Pediatr Cardiol"},{"key":"194_CR67","doi-asserted-by":"crossref","first-page":"13","DOI":"10.1017\/S1047951105000041","volume":"15","author":"K Plumpton","year":"2005","unstructured":"Plumpton K, Justo R, Haas N. Amiodarone for post-operative junctional ectopic tachycardia. Cardiol young. 2005;15:13\u20138.","journal-title":"Cardiol young"},{"key":"194_CR68","doi-asserted-by":"crossref","first-page":"261","DOI":"10.1136\/hrt.72.3.261","volume":"72","author":"P Raja","year":"1994","unstructured":"Raja P, Hawker RE, Chaikitpinyo A, et al. Amiodarone management of junctional ectopic tachycardia after cardiac surgery in children. Brit Heart J. 1994;72:261\u20135.","journal-title":"Brit Heart J"},{"key":"194_CR69","doi-asserted-by":"crossref","first-page":"3470","DOI":"10.1161\/CIRCULATIONAHA.105.534149","volume":"112","author":"JP Saul","year":"2005","unstructured":"Saul JP, Scott WA, Brown S, et al. Intravenous amiodarone for incessant tachyarrhythmias in children: a randomized, double-blind, antiarrhythmic drug trial. Circulation. 2005;112:3470\u20137.","journal-title":"Circulation"},{"key":"194_CR70","doi-asserted-by":"crossref","first-page":"152","DOI":"10.1016\/j.jtcvs.2011.09.042","volume":"143","author":"M Imamura","year":"2012","unstructured":"Imamura M, Dossey AM, Garcia X, et al. Prophylactic amiodarone reduces junctional ectopic tachycardia after tetralogy of Fallot repair. J Thorac Cardiovasc Surg. 2012;143:152\u20136.","journal-title":"J Thorac Cardiovasc Surg"},{"key":"194_CR71","doi-asserted-by":"crossref","first-page":"148","DOI":"10.1016\/S0003-4975(03)00192-9","volume":"76","author":"G Bronzetti","year":"2003","unstructured":"Bronzetti G, Formigari R, Giardini A, et al. Intravenous flecainide for the treatment of junctional ectopic tachycardia after surgery for congenital heart disease. Ann Thorac Surg. 2003;76:148\u201351.","journal-title":"Ann Thorac Surg"},{"key":"194_CR72","doi-asserted-by":"crossref","first-page":"1544","DOI":"10.1161\/01.CIR.81.5.1544","volume":"81","author":"E Villain","year":"1990","unstructured":"Villain E, Vetter VL, Garcia JM, et al. Evolving concepts in the management of congenital junctional ectopic tachycardia. A multicenter study. Circulation. 1990;81:1544\u20139.","journal-title":"Circulation"},{"key":"194_CR73","doi-asserted-by":"crossref","first-page":"188","DOI":"10.1136\/heart.88.2.188","volume":"88","author":"B Sarubbi","year":"2002","unstructured":"Sarubbi B, Musto B, Ducceschi V, et al. Congenital junctional ectopic tachycardia in children and adolescents: a 20 year experience based study. Heart. 2002;88:188\u201390.","journal-title":"Heart"},{"key":"194_CR74","doi-asserted-by":"crossref","first-page":"S876","DOI":"10.1161\/CIRCULATIONAHA.110.971101","volume":"122","author":"ME Kleinman","year":"2010","unstructured":"Kleinman ME, Chameides L, Schexnayder SM, et al. Part 14: pediatric advanced life support: 2010 American Heart Association Guidelines for Cardiopulmonary Resuscitation and Emergency Cardiovascular Care. Circulation. 2010;122:S876\u2013908.","journal-title":"Circulation"},{"key":"194_CR75","doi-asserted-by":"crossref","first-page":"186","DOI":"10.1016\/S0002-8703(96)90068-X","volume":"131","author":"AM Davis","year":"1996","unstructured":"Davis AM, Gow RM, McCrindle BW, Hamilton RM. Clinical spectrum, therapeutic management, and follow-up of ventricular tachycardia in infants and young children. Am Heart J. 1996;131:186\u201391.","journal-title":"Am Heart J"},{"key":"194_CR76","doi-asserted-by":"crossref","first-page":"641","DOI":"10.1017\/S1047951110000867","volume":"20","author":"MD Levin","year":"2010","unstructured":"Levin MD, Stephens P, Tanel RE, et al. Ventricular tachycardia in infants with structurally normal heart: a benign disorder. Cardiol Young. 2010;20:641\u20137.","journal-title":"Cardiol Young"},{"key":"194_CR77","doi-asserted-by":"crossref","first-page":"822","DOI":"10.1016\/j.jpeds.2006.08.076","volume":"149","author":"KC Harris","year":"2006","unstructured":"Harris KC, Potts JE, Fournier A, et al. Right ventricular outflow tract tachycardia in children. J Pediatr. 2006;149:822\u20136.","journal-title":"J Pediatr"},{"key":"194_CR78","doi-asserted-by":"crossref","first-page":"1725","DOI":"10.1016\/j.hrthm.2010.07.037","volume":"7","author":"S Wang","year":"2010","unstructured":"Wang S, Zhu W, Hamilton RM, et al. Diagnosis-specific characteristics of ventricular tachycardia in children with structurally normal hearts. Heart Rhythm. 2010;7:1725\u201331.","journal-title":"Heart Rhythm"},{"key":"194_CR79","doi-asserted-by":"crossref","first-page":"42","DOI":"10.1046\/j.1442-200x.2001.01323.x","volume":"43","author":"K Yasui","year":"2001","unstructured":"Yasui K, Shibata T, Yokoyama U, et al. Idiopathic sustained left ventricular tachycardia in pediatric patients. Pediatr Int. 2001;43:42\u20137.","journal-title":"Pediatr Int"},{"key":"194_CR80","first-page":"106","volume":"5","author":"K Srivathsan","year":"2005","unstructured":"Srivathsan K, Lester SJ, Appleton CP, et al. Ventricular tachycardia in the absence of structural heart disease. Indian Pacing Electrophysiol J. 2005;5:106\u201321.","journal-title":"Indian Pacing Electrophysiol J"},{"key":"194_CR81","doi-asserted-by":"crossref","first-page":"S51","DOI":"10.1016\/j.hrthm.2009.02.009","volume":"6","author":"ES Kaufman","year":"2009","unstructured":"Kaufman ES. Mechanisms and clinical management of inherited channelopathies: long QT syndrome, Brugada syndrome, catecholaminergic polymorphic ventricular tachycardia, and short QT syndrome. Heart Rhythm. 2009;6:S51\u20135.","journal-title":"Heart Rhythm"},{"key":"194_CR82","doi-asserted-by":"crossref","first-page":"96","DOI":"10.1016\/j.hlc.2011.10.008","volume":"21","author":"A Pflaumer","year":"2012","unstructured":"Pflaumer A, Davis AM. Guidelines for the diagnosis and management of Catecholaminergic Polymorphic Ventricular Tachycardia. Heart Lung Circ. 2012;21:96\u2013100.","journal-title":"Heart Lung Circ"},{"key":"194_CR83","unstructured":"Blaufox AD, Tristani-Firouzi M, Seslar S, et al. Congenital Long QT 3 in the Pediatric Population. Am J Cardiol 2012 (in press). International multicenter review of 42 children with LQT 3 and SCN5A mutation. Mexiletine caused a significant reduction in the QTc interval of treated patients. Treatment with mexiletine also eliminated ICD shocks in two patients with frequent appropriate ICD shocks."},{"key":"194_CR84","doi-asserted-by":"crossref","first-page":"2244","DOI":"10.1016\/j.jacc.2011.01.026","volume":"57","author":"C Werf van der","year":"2011","unstructured":"van der Werf C, Kannankeril PJ, Sacher F, et al. Flecainide therapy reduces exercise-induced ventricular arrhythmias in patients with catecholaminergic polymorphic ventricular tachycardia. J Am Coll Cardiol. 2011;57:2244\u201354.","journal-title":"J Am Coll Cardiol"},{"issue":"21","key":"194_CR85","doi-asserted-by":"crossref","first-page":"e1","DOI":"10.1016\/j.jacc.2008.02.032","volume":"51","author":"AE Epstein","year":"2008","unstructured":"Epstein AE, DiMarco JP, Ellenbogen KA, et al. ACC\/AHA\/HRS 2008 Guidelines for Device-Based Therapy of Cardiac Rhythm Abnormalities: a report of the American College of Cardiology\/American Heart Association Task Force on Practice Guidelines (Writing Committee to Revise the ACC\/AHA\/NASPE 2002 Guideline Update for Implantation of Cardiac Pacemakers and Antiarrhythmia Devices) developed in collaboration with the American Association for Thoracic Surgery and Society of Thoracic Surgeons. J Am Coll Cardiol. 2008;51(21):e1\u2013e62.","journal-title":"J Am Coll Cardiol"},{"key":"194_CR86","doi-asserted-by":"crossref","first-page":"446","DOI":"10.1111\/j.1540-8167.2006.00427.x","volume":"17","author":"CM Wolf","year":"2006","unstructured":"Wolf CM, Berul CI. Inherited conduction system abnormalities\u2014one group of disease, many genes. J Cardiovasc Electrophysiol. 2006;17:446\u201355.","journal-title":"J Cardiovasc Electrophysiol"},{"key":"194_CR87","doi-asserted-by":"crossref","first-page":"629","DOI":"10.1038\/clpt.1989.198","volume":"46","author":"ML Buck","year":"1989","unstructured":"Buck ML, Wiest D, Gillette PC, et al. Pharmacokinetics and pharmacodynamics of atenolol in children. Clin Pharmacol Ther. 1989;46:629\u201333.","journal-title":"Clin Pharmacol Ther"},{"key":"194_CR88","doi-asserted-by":"crossref","first-page":"296","DOI":"10.1007\/BF00798123","volume":"15","author":"BF Cuneo","year":"1994","unstructured":"Cuneo BF, Zales VR, Blahunka PC, Benson Jr DW. Pharmacodynamics and pharmacokinetics of esmolol, a short-acting beta-blocking agent, in children. Pediatr Cardiol. 1994;15:296\u2013301.","journal-title":"Pediatr Cardiol"},{"key":"194_CR89","doi-asserted-by":"crossref","first-page":"1195","DOI":"10.1016\/0735-1097(94)00513-P","volume":"25","author":"AL Fenrich Jr","year":"1995","unstructured":"Fenrich Jr AL, Perry JC, Friedman RA. Flecainide and amiodarone: combined therapy for refractory tachyarrhythmias in infancy. J Am Coll Cardiol. 1995;25:1195\u20138.","journal-title":"J Am Coll Cardiol"},{"key":"194_CR90","doi-asserted-by":"crossref","first-page":"573","DOI":"10.1016\/0002-9149(94)90746-3","volume":"74","author":"FH Figa","year":"1994","unstructured":"Figa FH, Gow RM, Hamilton RM, Freedom RM. Clinical efficacy and safety of intravenous Amiodarone in infants and children. Am J Cardiol. 1994;74:573\u20137.","journal-title":"Am J Cardiol"},{"key":"194_CR91","doi-asserted-by":"crossref","first-page":"496","DOI":"10.1002\/j.1552-4604.1998.tb05786.x","volume":"38","author":"S Ito","year":"1998","unstructured":"Ito S, Gow R, Verjee Z, et al. Intravenous and oral propafenone for treatment of tachycardia in infants and children: pharmacokinetics and clinical response. J Clin Pharmacol. 1998;38:496\u2013501.","journal-title":"J Clin Pharmacol"},{"key":"194_CR92","doi-asserted-by":"crossref","first-page":"1227","DOI":"10.1177\/106002809703101016","volume":"31","author":"SA Luedtke","year":"1997","unstructured":"Luedtke SA, Kuhn RJ, McCaffrey FM. Pharmacologic management of supraventricular tachycardias in children. Part 1: Wolff\u2013Parkinson\u2013White and atrioventricular nodal reentry. Ann Pharmacother. 1997;31:1227\u201343.","journal-title":"Ann Pharmacother"},{"key":"194_CR93","doi-asserted-by":"crossref","first-page":"1347","DOI":"10.1177\/106002809703101113","volume":"31","author":"SA Luedtke","year":"1997","unstructured":"Luedtke SA, Kuhn RJ, McCaffrey FM. Pharmacologic management of supraventricular tachycardias in children. Part 2: atrial flutter, atrial fibrillation, and junctional and atrial ectopic tachycardia. Ann Pharmacother. 1997;31:1347\u201359.","journal-title":"Ann Pharmacother"},{"key":"194_CR94","doi-asserted-by":"crossref","first-page":"28","DOI":"10.1007\/s002469900104","volume":"18","author":"JP Pfammatter","year":"1997","unstructured":"Pfammatter JP, Paul T. New antiarrhythmic drug in pediatric use: sotalol. Pediatr Cardiol. 1997;18:28\u201334.","journal-title":"Pediatr Cardiol"},{"key":"194_CR95","doi-asserted-by":"crossref","first-page":"144","DOI":"10.1016\/S0022-3476(79)80381-9","volume":"94","author":"AS Pickoff","year":"1979","unstructured":"Pickoff AS, Zies L, Ferrer PL, et al. High-dose propranolol therapy in the management of supraventricular tachycardia. J Pediatr. 1979;94:144\u20136.","journal-title":"J Pediatr"},{"key":"194_CR96","doi-asserted-by":"crossref","first-page":"607","DOI":"10.1038\/clpt.1982.210","volume":"32","author":"S Singh","year":"1982","unstructured":"Singh S, Gelband H, Mehta AV, et al. Procainamide elimination kinetics in pediatric patients. Clin Pharmacol Ther. 1982;32:607\u201311.","journal-title":"Clin Pharmacol Ther"},{"key":"194_CR97","doi-asserted-by":"crossref","first-page":"1312","DOI":"10.1016\/S0002-8703(05)80180-2","volume":"119","author":"DL Trippel","year":"1990","unstructured":"Trippel DL, Gillette PC. Atenolol in children with ventricular arrhythmias. Am Heart J. 1990;119:1312\u20136.","journal-title":"Am Heart J"},{"key":"194_CR98","doi-asserted-by":"crossref","first-page":"142","DOI":"10.1016\/S0022-3476(05)81055-8","volume":"119","author":"DL Trippel","year":"1991","unstructured":"Trippel DL, Wiest DB, Gillette PC. Cardiovascular and antiarrhythmic effects of esmolol in children. J Pediatr. 1991;119:142\u20137.","journal-title":"J Pediatr"},{"key":"194_CR99","unstructured":"Product information: Rythmol(R) SR, propafenone. Liberty Corner, NJ: Reliant Pharmaceuticals; 2003."},{"key":"194_CR100","doi-asserted-by":"crossref","first-page":"1933","DOI":"10.1161\/hc4101.097538","volume":"104","author":"KA Glatter","year":"2001","unstructured":"Glatter KA, Dorostkar PC, Yang Y, et al. Electrophysiological effects of ibutilide in patients with accessory pathways. Circulation. 2001;104:1933\u20139.","journal-title":"Circulation"}],"container-title":["Current Treatment Options in Cardiovascular Medicine"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s11936-012-0194-5.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1007\/s11936-012-0194-5\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s11936-012-0194-5","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2019,7,2]],"date-time":"2019-07-02T20:00:34Z","timestamp":1562097634000},"score":1,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.1007\/s11936-012-0194-5"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2012,8,21]]},"references-count":100,"journal-issue":{"issue":"5","published-print":{"date-parts":[[2012,10]]}},"alternative-id":["194"],"URL":"https:\/\/doi.org\/10.1007\/s11936-012-0194-5","relation":{},"ISSN":["1092-8464","1534-3189"],"issn-type":[{"value":"1092-8464","type":"print"},{"value":"1534-3189","type":"electronic"}],"subject":[],"published":{"date-parts":[[2012,8,21]]}}}